Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy

Status Completed

Clinical Trial Summary

Clinical Trial Description

Alfentanil (Alf) is used in combination with Propofol (Pro) in fiber-bronchoscopy and in many other conscious sedation procedures. Alf and Pro have the characteristic of rapid anesthetic onset and quick recovery, synergic sedative effect and unwanted side effects too. However, the amount of Alf needed in combination with Pro for induction and the timing of administration was no standardized. The investigators designed this study to evaluate the optimal regimen, dose and timing of Alf in Target-Controlled infusion (TCI) of Pro for flexible bronchoscopy sedation.

Method: patients will be enrolled and assigned randomly into five groups. In group 1, normal saline two minutes before and Alf 2.5μg/kg before Pro were given; In group 2, normal saline two minutes before and Alf 5μg/kg before Pro were given; In group 3, Alf 2.5μg/kg two minutes before and normal saline before Pro were given; In group 4: Alf 5μg/kg two minutes before and normal saline before Pro were given; in group 5, normal saline two minutes and before Pro were given.

Concentration of effect site to loss of consciousness (LOC), dose of Pro to LOC, and induction time of variable regimen, as well as hypoxemia, hypotension, cough severity, and Pro injection related pain will be recorded and analyzed. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Hypoxemia

Clinical Trial Details

NCT number	NCT01470170
Study type	Interventional
Source	Chang Gung Memorial Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	October 2010
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT03628560` - Alternate Methodology of Pulse Oximeter Validation	N/A
Completed	`NCT02866578` - Open Lung Protective Ventilation in Cardiac Surgery	N/A
Recruiting	`NCT06139081` - Oxygen Delivery Methods of Nasal Catheter on the Incidence of Hypoxemia in Patients With Painless Gastroscopy	N/A
Not yet recruiting	`NCT05964309` - Pre-oxygenation in Sitting Position and Oxygen Reserve Index	N/A
Completed	`NCT00675415` - Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?	N/A
Completed	`NCT00740220` - Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation	N/A
Completed	`NCT04557605` - Effects of a Face Mask on Oxygenation During Exercise	N/A
Active, not recruiting	`NCT05479929` - Work of Breathing Assessment in Triage Scale
Recruiting	`NCT05422430` - Rebreathing-induced Hypoxia and Glucose Levels	N/A
Recruiting	`NCT03009643` - Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery	N/A
Completed	`NCT01949012` - Capnography Monitoring During Intravenous Conscious Sedation Sedation With Midazolam for Oral Surgery	N/A
Completed	`NCT01477450` - Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects	N/A
Recruiting	`NCT06085859` - Anesthesia Endoscope Mask is Applied to Sedation Upper Gastrointestinal Endoscopic Diagnosis and Treatment	N/A
Recruiting	`NCT03969615` - SuperNO2VA™ and General Anesthesia Postoperative Care	N/A
Completed	`NCT02554110` - Peripheral Nerve Stimulation to Reduce Hypoxic Events	N/A
Completed	`NCT04566419` - poStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis Incidence	N/A
Completed	`NCT04998253` - Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2	Early Phase 1
Recruiting	`NCT04079465` - Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia	N/A
Recruiting	`NCT06022523` - Accuracy of Pulse Oximeters With Profound Hypoxia	N/A
Completed	`NCT04159116` - Prevention and Treatment of Laryngospasm and Hypoxemia Based on Risk Factors in Adult Outpatients Undergoing EGD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.